Search

Your search keyword '"Tsutsumi, Takeshi"' showing total 516 results

Search Constraints

Start Over You searched for: Author "Tsutsumi, Takeshi" Remove constraint Author: "Tsutsumi, Takeshi"
516 results on '"Tsutsumi, Takeshi"'

Search Results

1. Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma

5. The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer

9. Integration of Augmented Reality in Temporal Bone and Skull Base Surgeries.

13. Pattern of Expression of MicroRNA in Patients with Radiation-Induced Bladder Injury.

16. Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohort

17. Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~

20. Importance of periodic examinations after transplants; a case of pulmonary cryptococcosis after kidney transplantation

22. Tertiary lymphoid structure and neutrophil–lymphocyte ratio coordinately predict outcome of pembrolizumab

23. Early Clinical Presentations in 79 Patients with External Auditory Canal Carcinoma

25. The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in Japan

31. Optimal Time Point for Evaluation of Response to Pembrolizumab Treatment in Japanese Patients With Metastatic Urothelial Carcinoma

33. Prognostic impact of C-reactive protein-albumin ratio for the lethality in castration-resistant prostate cancer

37. Tissue Distribution of Cisplatin by Intra-arterial Infusion Route in Comparison to Systemic Route: Implication to Therapy for Node-positive Bladder Cancer

47. Prognostic value of the fluctuation in the neutrophil–lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma

Catalog

Books, media, physical & digital resources